Pharmacokinetics of metformin
Isnard, F.; Lavieuville, M.; Gut, M.
Journees Annuelles de Diabetologie de l'Hotel-Dieu 1980: 305-313
1980
ISSN/ISBN: 0075-4439 PMID: 7401427 Document Number: 154722
Document emailed within 1 workday
Related Documents
Kang, S.B.; Shon, H.S.; Park, S.J.; Lee, Y.J.; Ku, S.-K.; Song, C.-H. 2019: Effects of Yukmijihwang-tang, a Polyherb, on the Pharmacokinetics of Metformin Pakistan Journal of Pharmaceutical Sciences 32(5): 2025-2031Ma, Y.-r.; Wu, Y.-f.; Duan, Y.-q.; Zhang, G.-q.; Wu, X.-a. 2017: Effects of metoprolol or/and pravastatin on the pharmacokinetics of metformin in rats Yao Xue Xue Bao 52(2): 253-257
Duan, H.-G.; Wei, Y.-H.; Li, B.-X.; Zhang, D.-M.; Zhang, J.-W.; Wu, X.-A. 2008: Effects of Yuquan pills on pharmacokinetics of metformin hydrochloride in diabetic rats Zhongguo Zhong Yao Za Zhi 33(18): 2133-2135; 2139
Van Dijk, P.R.; Landman, G.W.D.; Bilo, H.J.G. 2012: Role of metformin in diabetes treatment--is metformin falling from grace? Nederlands Tijdschrift Voor Geneeskunde 156(43): A5297
Haydardedeoglu, B.; Simsek, E.; Kilicdag, E.B.; Bagis, T. 2009: Metabolic and endocrine effects of metformin and metformin plus cyclic medroxyprogesterone acetate in women with polycystic ovary syndrome International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics 105(1): 32-35
Bredella, M.A.; McManus, S.; Misra, M. 2013: Impact of metformin monotherapy versus metformin with oestrogen-progesterone on lipids in adolescent girls with polycystic ovarian syndrome Clinical Endocrinology 79(2): 199-203
Hague, W.M.; Davoren, P.M.; Oliver, J.; Rowan, J. 2003: Contraindications to use of metformin. Metformin may be useful in gestational diabetes Bmj 326(7392): 762; Author Reply 762
Moin, T. 2019: Should Adults with Prediabetes Be Prescribed Metformin to Prevent Diabetes Mellitus? Yes: High-Quality Evidence Supports Metformin Use in Persons at High Risk American Family Physician 100(3): 134-135
Brion, N.; Contrepois, A.; Carbon, C. 1983: From serum pharmacokinetics to extravascular pharmacokinetics of antibiotics. Importance of protein binding Presse Medicale 12(5): 293-296
Paxton, J.W. 1981: Elementary pharmacokinetics in clinical practice 4: genetic, environmental and age influences on pharmacokinetics New Zealand Medical Journal 94(697): 423-425
De Mey, C.; Scharpe, S.; De Bock, R.; Bossaert, L. 1981: Predictive pharmacokinetics of amikacin using actually measured and assumed parameters, applied in 1-compartment linear pharmacokinetics Archives Internationales de Pharmacodynamie et de Therapie 253(2): 323-324
Daniel, W.; Syrek, M.; Janczar, L.; Boksa, J. 1995: The pharmacokinetics of promazine and its metabolites after acute and chronic administration to rats--a comparison with the pharmacokinetics of imipramine Polish Journal of Pharmacology 47(2): 127-136
Lavieuville, M.; Brohon, J.; Gut, M. 1976: Lipoproteins and metformin Journees Annuelles de Diabetologie de l'Hotel-Dieu 1976: 349-354
Sieradzki, J. 1999: Renaissance of metformin Przeglad Lekarski 56(5): 331-334
Gray, L.; Lee, J.H.; Nashelsky, J. 2013: Metformin use in adolescents American Family Physician 87(8): Od4
Yamamoto, N.; Yanagi, K.; Matuyama, H.; Shimizu, K.; Mitsui, H.; Shimabukuro, T.; Yamamoto, M.; Sakatoku, J.; Fujita, T.; Matsuoka, K. 1987: Pharmacokinetics of high-dose cisplatin administration (relationship between pharmacokinetics and administration schedule) Hinyokika Kiyo. Acta Urologica Japonica 33(11): 1760-1765
Lenfestey, A.; Friedmann, D.; Burke, W.A. 2012: Metformin-induced pseudoporphyria Journal of Drugs in Dermatology: Jdd 11(11): 1272
Chong, W. 2004: Metformin and serious adverse effects Medical Journal of Australia 181(1): 56
Lavieuville, M. 1981: Metformin and insulin receptors Journees Annuelles de Diabetologie de l'Hotel-Dieu 1981: 309-311
Aquarius, M.; van Kuijk, W.H.M. 2007: Fatal autointoxication with metformin Nederlands Tijdschrift Voor Geneeskunde 151(32): 1809; Author Reply 1809